Cargando…

The Combination of Betahistine and Oxybutynin Increases Respiratory Control Sensitivity (Loop Gain) in People with Obstructive Sleep Apnea: A Randomized, Placebo-Controlled Trial

RATIONALE: There are widespread histaminergic projections throughout the brain, including hypoglossal nuclei, that modulate pharyngeal muscle tone and respiratory control. Hence, histaminergic stimulation pharmacologically may increase pharyngeal muscle tone and stabilize respiratory control (loop g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Messineo, Ludovico, Loffler, Kelly, Chiang, Alan, Osman, Amal, Taranto-Montemurro, Luigi, Eckert, Danny J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9188336/ https://www.ncbi.nlm.nih.gov/pubmed/35698591 http://dx.doi.org/10.2147/NSS.S362205

Ejemplares similares

P001 Safety, tolerability, and efficacy of 1 month of atomoxetine plus oxybutynin in obstructive sleep apnoea
por: Aishah, A, et al.
Publicado: (2021)

Targeting Endotypic Traits with Medications for the Pharmacological Treatment of Obstructive Sleep Apnea. A Review of the Current Literature
por: Taranto-Montemurro, Luigi, et al.
Publicado: (2019)

A novel transdermal nanoethosomal gel of betahistine dihydrochloride for weight gain control: in-vitro and in-vivo characterization
por: El-Menshawe, Shahira F, et al.
Publicado: (2017)

Efficacy of atomoxetine plus oxybutynin in the treatment of obstructive sleep apnea with moderate pharyngeal collapsibility
por: Schweitzer, Paula K., et al.
Publicado: (2022)

Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation
por: Perger, Elisa, et al.
Publicado: (2023)

Obstructive sleep apnea: current perspectives
por: Osman, Amal M, et al.
Publicado: (2018)

Long-term atomoxetine-oxybutynin combination use may be beneficial for the prevention of obstructive sleep apnea
por: Chen, Tien-Yu, et al.
Publicado: (2021)

Oxybutynin reduces sweating in depressed patients treated with sertraline: a double-blind, placebo-controlled, clinical study
por: Ghaleiha, Ali, et al.
Publicado: (2012)

Effect of Betahistine and Metformin on Antipsychotic-Induced Weight Gain: An Analysis of Two Clinical Trials
por: Kang, Dongyu, et al.
Publicado: (2018)

High-Dose Betahistine Improves Cognitive Function in Patients With Schizophrenia: A Randomized Double-Blind Placebo-Controlled Trial
por: Wang, Yongqian, et al.
Publicado: (2021)

Effects of Betahistine on Vestibulo-Ocular Reflex in Normal Healthy Adults: A Randomized Double-Blind, Placebo-Controlled Trial
por: Wan Hassan, Wan Ahmad Amiruddin, et al.
Publicado: (2022)

Betahistine in the treatment of Ménière’s disease
por: Lacour, Michel, et al.
Publicado: (2007)

Effects of Adjunctive Betahistine Therapy on Lipid Metabolism in Patients with Chronic Schizophrenia: A Randomized Double-Blind Placebo-Controlled Study
por: Bai, Luyuan, et al.
Publicado: (2023)

Oxybutynin: an overview of the available formulations
por: McCrery, Rebecca J, et al.
Publicado: (2006)

Oxybutynin as an alternative treatment for hyperhidrosis
por: Delort, Sergio, et al.
Publicado: (2017)

The scent of love is in the air(way): a potential drug target for sleep apnea?
por: Osman, Amal M, et al.
Publicado: (2023)

Inherent vs. Induced Loop Gain Abnormalities in Obstructive Sleep Apnea
por: Deacon-Diaz, Naomi, et al.
Publicado: (2018)

Reply to Patel and Althouse: Robust Methods Are Needed to Evaluate the Pharmacologic Treatment of Obstructive Sleep Apnea
por: Taranto-Montemurro, Luigi, et al.
Publicado: (2019)

Transdermal oxybutynin in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2006)

Methadone-Induced Hyperhidrosis Treated With Oxybutynin
por: Hong, Joe, et al.
Publicado: (2017)

Spectrophotometric estimation of betahistine hydrochloride in tablet formulations
por: Kumar, Amit, et al.
Publicado: (2010)

Betahistine in the treatment of tinnitus in patients with vestibular disorders
por: Ganança, Maurício Malavasi, et al.
Publicado: (2015)

Editorial: Obstructive Sleep Apnea and the Brain
por: Gouveris, Haralampos, et al.
Publicado: (2018)

Efficacy and Safety of Intranasal Betahistine in the Treatment of Surgery-Induced Acute Vestibular Syndrome: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Study
por: Van de Heyning, Paul, et al.
Publicado: (2023)

P018 The effects of zopiclone on sleep spindles in obstructive sleep apnea: A randomized placebo-controlled trial
por: Carter, S, et al.
Publicado: (2021)

Oxybutynin topical gel in the treatment of overactive bladder
por: Davila, G Willy
Publicado: (2010)

Atypical aquagenic keratoderma treated with oxybutynin chloride
por: Dixit, Niharika, et al.
Publicado: (2018)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Preventing Olanzapine-Induced Weight Gain Using Betahistine: A Study in a Rat Model with Chronic Olanzapine Treatment
por: Lian, Jiamei, et al.
Publicado: (2014)

Efficacy of betahistine in counteracting second-generation antipsychotics-induced weight gain: A meta-analysis with trial sequential analysis
por: Soliman, Y., et al.
Publicado: (2023)

Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience
por: Monzani, D., et al.
Publicado: (2012)

Point-of-care prediction model of loop gain in patients with obstructive sleep apnea: development and validation
por: Schmickl, Christopher N., et al.
Publicado: (2022)

Safety and efficacy of oxybutynin in patients with hyperhidrosis: systematic review and meta-analysis of randomized controlled trials
por: El-Samahy, Mohamed, et al.
Publicado: (2023)

Development of oxybutynin chloride topical gel for overactive bladder
por: Lucente, Vincent R, et al.
Publicado: (2011)

Factorial design-assisted spectroscopic determination of oxybutynin hydrochloride
por: Yosrey, Eman, et al.
Publicado: (2021)

Oxybutynin-Induced Hyperthermia in a Patient With Parkinson’s Disease
por: Ahmad, Saad, et al.
Publicado: (2021)

Hearing function after betahistine therapy in patients with Ménière's disease()
por: Seyed Tootoonchi, Seyed Javad, et al.
Publicado: (2015)

Efficacy of Tamsulosin, Oxybutynin, and their combination in the control of double-j stent-related lower urinary tract symptoms
por: Maldonado-Avila, Miguel, et al.
Publicado: (2016)

Betahistine add-on therapy for treatment of subjects with posterior benign paroxysmal positional vertigo: a randomized controlled trial
por: Sayin, Ibrahim, et al.
Publicado: (2020)

O001 Reboxetine reduces obstructive sleep apnea severity: a randomized trial
por: Altree, T, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_heer55csmgtjnm66k4jmev31t6